262 related articles for article (PubMed ID: 1386093)
1. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL.
Delibrias CC; Fischer E; Bismuth G; Kazatchkine MD
J Immunol; 1992 Aug; 149(3):768-74. PubMed ID: 1386093
[TBL] [Abstract][Full Text] [Related]
2. Expression of CR2 (the C3dg/EBV receptor, CD21) on normal human peripheral blood T lymphocytes.
Fischer E; Delibrias C; Kazatchkine MD
J Immunol; 1991 Feb; 146(3):865-9. PubMed ID: 1703182
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
[TBL] [Abstract][Full Text] [Related]
4. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
Kazatchkine MD; Fearon DT
Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
[TBL] [Abstract][Full Text] [Related]
5. CR2 ligands modulate human B cell activation.
Bohnsack JF; Cooper NR
J Immunol; 1988 Oct; 141(8):2569-76. PubMed ID: 2459218
[TBL] [Abstract][Full Text] [Related]
6. CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus.
Delibrias CC; Mouhoub A; Fischer E; Kazatchkine MD
Eur J Immunol; 1994 Nov; 24(11):2784-8. PubMed ID: 7957570
[TBL] [Abstract][Full Text] [Related]
7. Structure and signalling functions of C3 receptors on human B cells.
Frade R
Semin Immunol; 1990 Mar; 2(2):159-64. PubMed ID: 2151800
[TBL] [Abstract][Full Text] [Related]
8. Analysis of epitope expression and the functional repertoire of recombinant complement receptor 2 (CR2/CD21) in mouse and human cells.
Carel JC; Frazier B; Ley TJ; Holers VM
J Immunol; 1989 Aug; 143(3):923-30. PubMed ID: 2473114
[TBL] [Abstract][Full Text] [Related]
9. Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes.
Leslie RG; Prodinger WM; Nielsen CH
Eur J Immunol; 2003 Dec; 33(12):3311-21. PubMed ID: 14635039
[TBL] [Abstract][Full Text] [Related]
10. Human lymphocytes shed a soluble form of CD21 (the C3dg/Epstein-Barr virus receptor, CR2) that binds iC3b and CD23.
Frémeaux-Bacchi V; Bernard I; Maillet F; Mani JC; Fontaine M; Bonnefoy JY; Kazatchkine MD; Fischer E
Eur J Immunol; 1996 Jul; 26(7):1497-503. PubMed ID: 8766552
[TBL] [Abstract][Full Text] [Related]
11. Ligation of the functional domain of complement receptor type 2 (CR2, CD21) is relevant for complex formation in T cell lines.
Prodinger WM; Larcher C; Schwendinger M; Dierich MP
J Immunol; 1996 Apr; 156(7):2580-4. PubMed ID: 8786322
[TBL] [Abstract][Full Text] [Related]
12. Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.
Hatzfeld A; Fischer E; Levesque JP; Perrin R; Hatzfeld J; Kazatchkine MD
J Immunol; 1988 Jan; 140(1):170-5. PubMed ID: 2826586
[TBL] [Abstract][Full Text] [Related]
13. gp140, a C3b-binding membrane component of lymphocytes, is the B cell C3dg/C3d receptor (CR2) and is distinct from the neutrophil C3dg receptor (CR4).
Frade R; Myones BL; Barel M; Krikorian L; Charriaut C; Ross GD
Eur J Immunol; 1985 Dec; 15(12):1192-7. PubMed ID: 3878789
[TBL] [Abstract][Full Text] [Related]
14. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2.
Kalli KR; Ahearn JM; Fearon DT
J Immunol; 1991 Jul; 147(2):590-4. PubMed ID: 1830068
[TBL] [Abstract][Full Text] [Related]
15. Complement opsonization is required for presentation of immune complexes by resting peripheral blood B cells.
Boackle SA; Morris MA; Holers VM; Karp DR
J Immunol; 1998 Dec; 161(12):6537-43. PubMed ID: 9862679
[TBL] [Abstract][Full Text] [Related]
16. Distinct epitopes on the T cell antigen receptor of HPB-ALL tumor cells identified by monoclonal antibodies.
Lanier LL; Ruitenberg JJ; Allison JP; Weiss A
J Immunol; 1986 Oct; 137(7):2286-92. PubMed ID: 2428866
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies to the human C3b/C4b receptor (CR1) enhance specific B cell differentiation.
Weiss L; Delfraissy JF; Vazquez A; Wallon C; Galanaud P; Kazatchkine MD
J Immunol; 1987 May; 138(9):2988-93. PubMed ID: 2952731
[TBL] [Abstract][Full Text] [Related]
18. Modulation of signaling via the B cell antigen receptor by CD21, the receptor for C3dg and EBV.
Luxembourg AT; Cooper NR
J Immunol; 1994 Nov; 153(10):4448-57. PubMed ID: 7525704
[TBL] [Abstract][Full Text] [Related]
19. Monovalent ligands of complement receptor 2 inhibit whereas polyvalent ligands enhance anti-Ig-induced human B cell intracytoplasmic free calcium concentration.
Tsokos GC; Lambris JD; Finkelman FD; Anastassiou ED; June CH
J Immunol; 1990 Mar; 144(5):1640-5. PubMed ID: 2137840
[TBL] [Abstract][Full Text] [Related]
20. Human complement receptor type 2 (CR2/CD21) transgenic mice provide an in vivo model to study immunoregulatory effects of receptor antagonists.
Kulik L; Chen K; Huber BT; Holers VM
Mol Immunol; 2011 Mar; 48(6-7):883-94. PubMed ID: 21269698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
